Article
Dopamine-containing neurons in the mammalian central nervous system: Electrophysiology and pharmacology

https://doi.org/10.1016/S0149-7634(88)80073-3Get rights and content

A decade of research culminated in the late 1950's with the demonstration that dopamine was a chemical neurotransmitter within the mammalian brain. Since this time, dopaminergic neuronal systems have been extensively studied using numerous techniques. This paper will review the last 14 years of electrophysiological investigation on neurochemically identified dopamine-containing neurons in the central nervous system. This will include an examination of both the electrophysiological and pharmacological characteristics in these cells, as well as the resulting insights into the regulation of dopamine cell electrical activity which is derived from this work.

References (436)

  • BessonM.J. et al.

    Effects of amphetamine and desmethylimipramine on amine synthesis and release in central catecholamine-containing neurons

    Eur J Pharmacol

    (1969)
  • BjörklundA. et al.

    Dopamine in dendrites of substantia nigra neurons: Suggestions for a role in dendritic terminals

    Brain Res

    (1975)
  • BloomF.E.

    To spritz or not to spritz: The doubtful value of aimless iontophoresis

    Life Sci

    (1974)
  • BrennemanA.R. et al.

    The role of tetrahydropteridines in the enzymatic conversion of tyrosine to 3,4-dihydroxyphenylalanine

    Biochem Biophys Res Commun

    (1964)
  • BrowderS. et al.

    Midbrain dopamine neurons: Differential responses to amphetamine isomers

    Brain Res

    (1981)
  • BrownsteinM.J. et al.

    On the origin of substance P and glutamic acid decarboxylase in the substantia nigra

    Brain Res

    (1977)
  • BunneyB.S. et al.

    Electrophysiological effects of amphetamine on dopaminergic neurons

  • BunneyB.S. et al.

    A comparison of the effects of chlorpromazine, 7-hydroxychlorpromazine and chlorpromazine sulfoxide on the activity of central dopaminergic neurons

    Life Sci

    (1974)
  • BunneyB.S. et al.

    The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique

    Brain Res

    (1976)
  • BurkiH.R. et al.

    Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat

    Eur J Pharmacol

    (1974)
  • CheramyA. et al.

    Effect of immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons

    Brain Res

    (1978)
  • ChiodoL.A. et al.

    Reciprocal influences of activating and immobilizing stimuli on the activity of nigro-striatal dopamine neurons

    Brain Res

    (1979)
  • ChiodoL.A. et al.

    Estrogen increases both spiperone-induced catalepsy and brain levels of 3H-spiperone in the rat

    Brain Res

    (1979)
  • ChiodoL.A. et al.

    Sensory stimuli alter the discharge rate of dopamine neurons: Evidence for two types of DA cells in the substantia nigra

    Brain Res

    (1980)
  • ChiodoL.A. et al.

    Alterations in basal firing rate and autoreceptor sensitivity of dopamine neurons in the substantia nigra following acute and extended exposure to estrogen

    Eur J Pharmacol

    (1980)
  • ChiodoL.A. et al.

    Electrophysiological studies on EMD 23 448, an indolyl-3-butylamine, in the rat: A putative selective dopamine autoreceptor agonist

    Neuropharmacology

    (1983)
  • ChiodoL.A. et al.

    Substantia nigra dopamine neurons: Alterations in basal discharge rates and autoreceptor sensitivity induced by estrogen

    Neuropharmacology

    (1983)
  • AghajanianG.K. et al.

    Lysergic acid diethylamide: Sensitive neuronal units in the midbrain raphe

    Science

    (1968)
  • AghajanianG.K. et al.

    Pre- and postsynaptic feedback mechanisms in central dopaminergic neurons

  • AghajanianG.K. et al.

    Dopamine “autoreceptors.” Pharmacological characterization by microiontophoretic single cell recording studies

    Naunyn Schmiedebergs Arch Pharmacol

    (1977)
  • AghajanianG.K. et al.

    Intracellular identification of central noradrenergic and serotoninergic neurons by a new double labelling procedure

    J Neurosci

    (1982)
  • AkilH. et al.

    Endogenous opioids: Biology and function

    Annu Rev Neurosci

    (1984)
  • AndénN.E. et al.

    Effects of clozapine on the turnover of dopamine in corpus striatum and in the limbic system

    J Pharmacol

    (1973)
  • AngristB.M. et al.

    The phenomenology of experimentally induced psychosis—preliminary observations

    Biol Psychiatry

    (1970)
  • AngristB.

    Psychoses induced by central neurons system stimulants and related drugs

  • AntelmanS.M. et al.

    Dopamine autoreceptor subsensitivity: A mechanism common to the treatment of depression and the induction of amphetamine psychosis?

    Biol Psychiatry

    (1981)
  • ArnericS.P. et al.

    RDS-127 (z-di-n-propylamino-4,7-dimethoxyindane); central effects of new dopamine receptor agonists

    J Pharmacol Exp Ther

    (1983)
  • BaileyR. et al.

    A pharmacological study of changes in CNS receptors responsiveness after long-term dextroamphetamine and apomorphine administration

    Psychopharmacology (Berlin)

    (1978)
  • BaldessariniR.J. et al.

    Mechanisms underlying tardive dyskinesia

  • BannonM.J. et al.

    Presynaptic dopamine receptors: Insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol

    Naunyn Schmiedebergs Arch Pharmacol

    (1980)
  • BannonM.J. et al.

    Evidence for an irreversible interaction of bromocriptine with central dopamine receptors

    Naunyn Schmiedebergs Arch Pharmacol

    (1980)
  • BannonM.J. et al.

    Mesocortical dopamine neurons: Lack of autoreceptors modulating dopamine synthesis

    Mol Pharmacol

    (1981)
  • BannonM.J. et al.

    Mesocortical dopamine neurons: Rapid transmitter turnover compared to other brain catecholamine systems

    Brain Res

    (1981)
  • BannonM.J. et al.

    Unique response to antipsychotic drugs is due to the absence of terminal autoreceptors in mesocortical dopamine neurons

    Nature

    (1982)
  • BannonM.J. et al.

    Pharmacology of mesocortical dopamine neurons

    Pharmacol Rev

    (1983)
  • BannonM.J. et al.

    In vivo biochemical and electrophysiological studies on the distribution and pharmacology of dopamine autoreceptors

  • BannonM.J. et al.

    The electrophysiological and biochemical pharmacology of the mesolimbic and mesocortical dopamine neurons

  • BarbeauA.

    Preliminary observation on abnormal catecholamine metabolism in basal ganglia disease

    Neurology

    (1960)
  • BarbeauA.

    The clinical physiology of side effects in long-term L-DOPA therapy

    Adv Neurol

    (1974)
  • BartholiniG. et al.

    Effects of clozapine on central catecholaminergic neurone systems

    Br J Pharmacol

    (1972)
  • Cited by (0)

    View full text